| ADSCs | Adipose-derived stem cells |
| Ang-2 | Angiopoeitin-2 |
| BM-MSCs | Bone marrow-mesenchymal stem cells |
| CSF | Colony stimulating factor |
| Coll–CS | Collagen–chondroitin sulfate |
| CM | Conditioned media |
| ECM | Extracellular matrix |
| EDAC/NHS | N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride/N-Hydroxysuccinimide |
| FDA | Food and Drug Administration |
| GAS | Gene-activated scaffold |
| HUVECs | Human umbilical vein endothelial cells |
| IGFBP-3 | Insulin growth factor binding protein-3 |
| IL-8 | Interleukin-8 |
| MCP-1 | Monocyte chemoattractant protein-1 |
| PAI-1 | Plasminogen activator inhibitor-1 |
| pDNA | Plasmid DNA |
| PEI | Polyethyleneimine |
| PEDF | Pigment epithelium-derived factor |
| SDF-1α | Stromal-derived factor-1 alpha |
| TIMP-1 | Tissue inhibitor of metalloproteinase-1 |
| TSP-1 | Thrombospondin-1 |
| VEGF | Vascular endothelial growth factor |